Söndag 17 Maj | 17:35:29 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2026-11-03 07:00 Kvartalsrapport 2026-Q3
2026-08-18 07:00 Kvartalsrapport 2026-Q2
2026-06-10 N/A X-dag ordinarie utdelning OSSD 0.00 SEK
2026-06-09 N/A Årsstämma
2026-05-05 - Kvartalsrapport 2026-Q1
2026-02-03 - Bokslutskommuniké 2025
2025-11-04 - Kvartalsrapport 2025-Q3
2025-08-19 - Kvartalsrapport 2025-Q2
2025-06-12 - X-dag ordinarie utdelning OSSD 0.00 SEK
2025-06-11 - Årsstämma
2025-05-06 - Kvartalsrapport 2025-Q1
2025-02-04 - Bokslutskommuniké 2024
2024-12-18 - Extra Bolagsstämma 2024
2024-11-12 - Kvartalsrapport 2024-Q3
2024-08-20 - Kvartalsrapport 2024-Q2
2024-05-22 - X-dag ordinarie utdelning OSSD 0.00 SEK
2024-05-21 - Årsstämma
2024-05-14 - Kvartalsrapport 2024-Q1
2024-02-06 - Bokslutskommuniké 2023
2023-11-21 - Kvartalsrapport 2023-Q3
2023-10-16 - Extra Bolagsstämma 2023
2023-08-22 - Kvartalsrapport 2023-Q2
2023-06-01 - X-dag ordinarie utdelning OSSD 0.00 SEK
2023-05-31 - Årsstämma
2023-05-23 - Kvartalsrapport 2023-Q1
2023-02-21 - Bokslutskommuniké 2022
2022-11-22 - Kvartalsrapport 2022-Q3
2022-08-23 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning OSSD 0.00 SEK
2022-06-02 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-02-22 - Bokslutskommuniké 2021
2021-11-17 - Kvartalsrapport 2021-Q3
2021-08-18 - Kvartalsrapport 2021-Q2
2021-05-20 - X-dag ordinarie utdelning OSSD 0.00 SEK
2021-05-19 - Årsstämma
2021-05-12 - Kvartalsrapport 2021-Q1
2021-04-09 - Extra Bolagsstämma 2021
2021-02-11 - Bokslutskommuniké 2020
2020-11-11 - Kvartalsrapport 2020-Q3
2020-08-19 - Kvartalsrapport 2020-Q2
2020-05-22 - X-dag ordinarie utdelning OSSD 0.00 SEK
2020-05-20 - Årsstämma
2020-05-13 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-11-19 - Kvartalsrapport 2019-Q3
2019-08-21 - Kvartalsrapport 2019-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
OssDsign är en utvecklare och leverantör av ortobiologiska produkter. Bolaget utvecklar och marknadsför produkter som stödjer kroppens egen läkningsförmåga, exempelvis OssDsign Catalyst, som är ett nanosyntetiskt bentransplantat för dubbla benbildningsvägar genom fusionsmassa. Bolaget erbjuder sina produkter runtom den globala marknaden. OssDsign grundades 2011 och har sitt huvudkontor i Uppsala.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-05-05 07:00:00

Reset: Laying the groundwork for accelerated growth

OssDsign AB (publ) announces that the interim report for Q1 2026 is now available as a PDF on the company's website www.ossdsign.com/reports. A PDF version is also attached to this press release.

The Q1 2026 results will also be presented at an investor webcast today May 5th at 11:00 CEST. The webcast can be accessed via the following link: https://qcnl.tv/p/J21zZyaq3hj3uEnQwRNXOg or via the OssDsign website.  

 

The first quarter in figures

  • Net sales amounted to TSEK 36,879 (44,493), which translates to a decrease of 3.6% compared to the first quarter of 2025 at constant exchange rates, or 17.1% in reported figures. The significant divergence in growth rates is entirely attributable to the exchange rate depreciation of the USD relative to the SEK during the comparison periods.
  • Gross margin of 91.6% (96.4%), with the decrease deriving, in part, from the lower sales in the period but primarily from temporary mix effects.
  • Reported EBIT of TSEK -13,466 (-12,697), with the comparison period affected by LTIP related costs for the 2024-28 program.
  • Adjusted EBIT of TSEK -13,389 (-5,563), adjusted for LTIP related costs in both periods.
  • Operating expenses were lower than last year, even after LTIP adjustments, with the main driver being the lower sales variable costs. Sales commissions and fees were down to 47.1% (49.3%) of net sales in the period.
  • Net result for the period amounted to TSEK -11,473 (-14,577).
  • Earnings per share of SEK -0.1 (-0.1).
  • Cash flow from operating activities of TSEK -14,866 (-25,874), due to a positive working capital development. The comparison period was negatively affected by MSEK -7 in LTIP related payments.

 

Significant events during the first quarter

  • There were no significant events during the first quarter.

 

Significant events after the end of the first quarter

  • OssDsign provides pre-release update on Q1 2026 performance.

    This disclosure contains information that OssDsign AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 05-05-2026 07:00 CET.